A site‐selective approach targeting the Hsp90 N‐terminal binding pocket, specifically for cytosolic isoforms α and β over Grp94 and TRAP‐1, has been emphasized in Huntington's disease (HD) [18, 128]. Here, HSP90B1 is linked to Huntington disease.